Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy (Q37651901)

21 August 2017

1 reference

title

Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy (English)

1 reference

21 August 2017

Tsuyoshi Kasama

1

1 reference

21 August 2017

Kuninobu Wakabayashi

2

1 reference

21 August 2017

Michihito Sato

3

1 reference

21 August 2017

Ryo Takahashi

4

1 reference

21 August 2017

Takeo Isozaki

5

1 reference

21 August 2017

publication date

1 January 2010

1 reference

21 August 2017

published in

Translational Research

1 reference

21 August 2017

volume

155

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

20-26

1 reference

Endothelial cells, fibroblasts and vasculitis

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Therapeutic targeting of molecules involved in leukocyte-endothelial cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Inflammation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Chemokines and leukocyte traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Chemokines: multiple levels of leukocyte migration control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Cytokines as communication signals between leukocytes and endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Pathogenesis of vasculitis syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Chemokines in the pathogenesis of vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Tissue targeting and disease patterns in systemic vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Expression of DARC, CXCR3 and CCR5 in giant cell arteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

A new class of membrane-bound chemokine with a CX3C motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

C and CX3C chemokines: cell sources and physiopathological implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Fractalkine and vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Fractalkine in vascular biology: from basic research to clinical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Circulating intercellular adhesion molecule 1 in rheumatoid arthritis — Relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: Relationship to systematic vasculitis and microvascular capillaroscopic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

The role of fractalkine in the recruitment of monocytes to the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Upregulation of fractalkine in human crescentic glomerulonephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Selective lymphocyte chemokine receptor expression in the rheumatoid joint

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Weighing the evidence for infection as a risk factor for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

The role of chemokines in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic Lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Generation and analysis of mice lacking the chemokine fractalkine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.08.009

10.1016/J.TRSL.2009.08.009

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference